Among the ip-lncRNAs ubiquitously down-regulated (see Supplemental Table S3), MIR99AHG has been identified in many different tumor types, including leukemia, breast, vulvar, prostate, and bladder cancer (Emmrich et al. 2014; Sun et al. 2014; Gökmen-Polar et al. 2016; Ni et al. 2016; Li et al. 2017). Here, MIR99AHG is linked to leukemia.